Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001787306-26-000020
Filing Date
2026-02-25
Accepted
2026-02-25 16:16:34
Documents
18
Effectiveness Date
2026-02-25

Document Format Files

Seq Description Document Type Size
1 S-3ASR arcutis-sx3asrfeb26.htm S-3ASR 278677
2 EX-FILING FEES exfilingfees.htm   iXBRL EX-FILING FEES 47510
3 EX-4.5 exhibit45-sx3asrindenturef.htm EX-4.5 468196
4 EX-5.1 exhibit51-sx3asrlathamopin.htm EX-5.1 37376
5 EX-23.1 exhibit231-sx3asrauditorco.htm EX-23 2480
6 EX-25.1 exhibit251-formtx1.htm EX-25.1 167113
7 image_0.jpg GRAPHIC 4258
8 logo1b.jpg GRAPHIC 98116
  Complete submission text file 0001787306-26-000020.txt   1272775

Data Files

Seq Description Document Type Size
21 EXTRACTED XBRL INSTANCE DOCUMENT exfilingfees_htm.xml XML 9865
Mailing Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361
Business Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361 805-418-5006
Arcutis Biotherapeutics, Inc. (Filer) CIK: 0001787306 (see all company filings)

EIN.: 812974255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-293736 | Film No.: 26678842
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)